Schedule 13D ownership disclosure

LANTERN PHARMA INC

Security class unavailable · CUSIP: 51654W101

Event date: 2020-06-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-176446
Form type
SC 13D
Filer
Bios Equity Partners, LP
CIK
CIK 1813314
Filed
Jun 23, 2020
Reporting period
Jun 15, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub